Multidrug resistance associated with extended-spectrum beta-lactamase (ESBL) and
Klebsiella pneumoniae carbapenemase (KPC) among K. pneumoniae is endemic in southern …

Small-cell lung cancer (SCLC), an aggressive neuroendocrine tumor with early dissemination
and dismal prognosis, accounts for 15–20% of lung cancer cases and ∼200,000 deaths …

Background We evaluated the incidence of invasive pulmonary aspergillosis among
intubated patients with critical COVID-19 and evaluated different case definitions of invasive …

… F, In vitro sensitivity of 40 cancer cell lines treated with BI-3406 in 3-D proliferation assays. …
Images were evaluated by a pathologist (F. Trapani) and H-score was generated using …

… , as suggested by an increased level of plasma glycerol (Figure S1E) and increased expression
of genes involved in lipolysis and mitochondrial oxidation in adipose tissue (Figure S1F)…

Purpose: The monocarboxylate transporter 1 (MCT1) inhibitor, AZD3965, is undergoing phase
I evaluation in the United Kingdom. AZD3965 is proposed, via lactate transport modulation…

… (F) Summary of phagocytosis assays using human macrophages and calcein AM–labeled
SCLC cell lines (left) or primary NJH29 SCLC cells as analyzed by flow cytometry. SCLC cells …

Small cell lung cancer (SCLC) is characterized by prevalent circulating tumour cells (CTCs),
early metastasis and poor prognosis. We show that SCLC patients (37/38) have rare CTC …

Although small cell lung cancer (SCLC) is treated as a homogeneous disease, biopsies and
preclinical models reveal heterogeneity in transcriptomes and morphology. SCLC subtypes …

… F Trapani2, … Sections were examined under an Olympus BX61 fluorescence microscope
(Olympus) and images captured with 10× and 20× magnifications using a F-VIEW II camera (…